United Therapeutics buy UBS Group AG
Start price
30.06.25
/
50%
€244.10
Target price
30.06.26
€328.48
Performance (%)
66.82%
Price
17.02.26
€407.20
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for United Therapeutics has seen massive gains of 66.82%. This prediction currently runs until 30.06.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | 2.389% | 2.389% |
| iShares Core DAX® | 0,19 % | -1,22 % |
| iShares Nasdaq 100 | -1,35 % | -5,31 % |
| iShares Nikkei 225® | -0,43 % | 7,32 % |
| iShares S&P 500 | -1,01 % | -3,40 % |
Comments by UBS_Group_AG for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics Corporation (NASDAQ: UTHR) had its price target lowered by analysts at UBS Group AG from $410.00 to $385.00. They now have a "buy" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by UBS_Group_AG for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€426.10
06.01.26
06.01.26
€550.12
06.01.27
06.01.27
-4.62%
17.02.26
17.02.26
United Therapeutics
Start price
Target price
Perf. (%)
€393.20
06.11.25
06.11.25
€521.34
06.11.26
06.11.26
3.56%
17.02.26
17.02.26
United Therapeutics
Start price
Target price
Perf. (%)
€360.40
29.09.25
29.09.25
€494.80
29.09.26
29.09.26
12.99%
17.02.26
17.02.26
United Therapeutics
Start price
Target price
Perf. (%)
€337.60
04.09.25
04.09.25
€480.20
04.09.26
04.09.26
20.62%
17.02.26
17.02.26
United Therapeutics
Start price
Target price
Perf. (%)
€258.80
13.08.25
13.08.25
€355.41
13.08.26
13.08.26
57.34%
17.02.26
17.02.26
United Therapeutics
Start price
Target price
Perf. (%)
€355.30
08.01.25
08.01.25
€460.94
08.01.26
08.01.26
17.73%
09.01.26
09.01.26
United Therapeutics
Start price
Target price
Perf. (%)
€292.80
08.07.24
08.07.24
€341.51
08.07.25
08.07.25
-14.82%
09.07.25
09.07.25